- Home
- NCSM vs MAIA Comparison
NCSM vs MAIA Comparison
Compare NCSM & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- MAIA
- Stock Information
- Founded
- NCSM 2006
- MAIA 2018
- Country
- NCSM United States
- MAIA United States
- Employees
- NCSM N/A
- MAIA N/A
- Industry
- NCSM Oilfield Services/Equipment
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- MAIA Health Care
- Exchange
- NCSM Nasdaq
- MAIA Nasdaq
- Market Cap
- NCSM 51.9M
- MAIA 52.7M
- IPO Year
- NCSM 2017
- MAIA 2022
- Fundamental
- Price
- NCSM $24.72
- MAIA $2.09
- Analyst Decision
- NCSM
- MAIA
- Analyst Count
- NCSM 0
- MAIA 0
- Target Price
- NCSM N/A
- MAIA N/A
- AVG Volume (30 Days)
- NCSM 14.8K
- MAIA 249.1K
- Earning Date
- NCSM 10-30-2024
- MAIA 11-12-2024
- Dividend Yield
- NCSM N/A
- MAIA N/A
- EPS Growth
- NCSM N/A
- MAIA N/A
- EPS
- NCSM 16.77
- MAIA N/A
- Revenue
- NCSM $152,801,000.00
- MAIA N/A
- Revenue This Year
- NCSM $13.26
- MAIA N/A
- Revenue Next Year
- NCSM $6.32
- MAIA N/A
- P/E Ratio
- NCSM $1.46
- MAIA N/A
- Revenue Growth
- NCSM 3.66
- MAIA N/A
- 52 Week Low
- NCSM $14.47
- MAIA $0.99
- 52 Week High
- NCSM $28.73
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- NCSM 51.73
- MAIA 47.03
- Support Level
- NCSM $23.03
- MAIA $1.92
- Resistance Level
- NCSM $26.13
- MAIA $2.16
- Average True Range (ATR)
- NCSM 1.46
- MAIA 0.20
- MACD
- NCSM -0.35
- MAIA 0.02
- Stochastic Oscillator
- NCSM 29.65
- MAIA 28.00
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.